Industry Discovery & Development Partnership Program
The Breakthrough T1D IDDP Program funds for-profit research advancing new therapies or devices for type 1 diabetes, focusing on projects with clear clinical or commercial impact.
Funder: Breakthrough T1D
Due Dates: Rolling (LOIs accepted year-round)
Funding Amounts: No set maximum; funding amount and duration as approved per project; matching funds from company required.
Summary: Supports for-profit entities in research and development of therapies, devices, or technologies for type 1 diabetes aligned with Breakthrough T1D’s priorities.
Key Information: LOI required before full proposal; matching company funds required; no indirect costs permitted.
Description
The Industry Discovery & Development Partnership (IDDP) Program from Breakthrough T1D provides funding to biotechnology, pharmaceutical, device, and other for-profit entities for research projects closely aligned with Breakthrough T1D’s priority research areas. The program aims to accelerate the discovery, development, and commercialization of therapeutics and devices for the treatment, cure, and prevention of type 1 diabetes (T1D). The IDDP leverages the translational and commercial expertise of industry partners in collaboration with Breakthrough T1D’s leadership in global T1D research and advocacy. Projects must have a clear path to clinical or commercial impact for the T1D community.
